J. Hiltunen

S. Nilsson, J. Hiltunen, M. Márquez, 2000, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Iodine-123 labelledN-(2-fluoroethyl)-2β-carbomethoxy-3β-(4-iodophenyl)nortropane for dopamine transporter imaging in the living human brain

J. Karhu, J. Tiihonen, J. Neumeyer, 1995, European Journal of Nuclear Medicine.

The metabolism of iodine‐123 labelled 3‐(5‐cyclopropyl‐1,2,4‐oxadiazo‐3‐yl)‐7‐iodo‐5,6‐dihydro‐5‐methyl‐6‐oxo‐4H‐imidazo[1,5‐a][1,4]benzodiazepine (NNC 13–8241) measured in human plasma is only minor

J. Tiihonen, C. Halldin, C. Foged, 1998 .

The metabolite pattern of [123I]β-CIT determined with a gradient HPLC method

J. Tiihonen, C. Halldin, L. Farde, 1995 .

Lipophilic metabolite of [123I]β‐CIT in human plasma may obstruct quantitation of the dopamine transporter

J. Tiihonen, C. Halldin, L. Farde, 1995, Synapse.

First Evaluation in Humans of [123I]PE2I: A Selective Radioligand for Visualization of the Striatal Dopamine Transporter Density

J. Karhu, J. Tiihonen, C. Halldin, 1999 .

Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imaging

J. Karhu, J. Tiihonen, V. Kolehmainen, 1998, European Journal of Nuclear Medicine.

Pharmacokinetics and Biodistribution of [123I]β-CIT in Humans

E. Vanninen, E. Länsimies, J. Kuikka, 1995 .

A novel somatostatin conjugate with a high affinity to all five somatostatin receptor subtypes

S. Nilsson, R. Arnold, A. Pfestroff, 2002, Cancer.

Biodistribution, blood half-life, and receptor binding of a somatostatin-dextran conjugate

S. Nilsson, M. Béhé, T. Behr, 2001, Medical oncology.

111In-labelled bleomycin complex for the differentiation of high- and low-grade gliomas.

S. Savolainen, H. Aronen, M. Kallio, 1999, Nuclear medicine communications.

Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results

K. Bergström, A. Ahonen, T. Kauppinen, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Synthesis of 5‐[123I]iodonicotinamide and biodistribution in rat

H. Mussalo, E. Länsimies, J. Kuikka, 1993 .

Dopamine transporter and D2-receptor density in late-onset alcoholism

Jari Karhu, Jari Tiihonen, J. Karhu, 1999, Psychopharmacology.

In Vitro Ligand Binding Kinetics Explains the Pharmacokinetics of [18F]FE-PE2I in Dopamine Transporter PET Imaging.

J. Järv, J. Hiltunen, S. Kukk, 2018, ACS medicinal chemistry letters.

Striatal Dopamine transporter in Parkinson's disease: A Study With a New Radioligand, [(123)I]B-CIT-FP.

J. Rinne, J. Kuikka, K. Bergström, 1997, Parkinsonism & related disorders.

Measurement of the Striatal Dopamine Transporter Density and Heterogeneity in Type 1 Alcoholics Using Human Whole Hemisphere Autoradiography

J. Tiihonen, H. Hall, J. Kuikka, 2001, NeuroImage.

Dopamine D2/D3-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics

J. Tiihonen, H. Hall, K. Bergström, 2001, Molecular Psychiatry.

Initial human studies with single-photon emission tomography using iodine-123 labelled 3-(5-cyclopropyl-1,2,4-oxadiazo-3-yl)-7-iodo-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine (NNC 13-8241)

Christer Halldin, Lars Farde, Jyrki T. Kuikka, 1996, European Journal of Nuclear Medicine.

Striatal and extrastriatal imaging of dopamine D2 receptors in the living human brain with [123I]epidepride single-photon emission tomography

Christer Halldin, Esko Vanninen, Jyrki T. Kuikka, 1997, European Journal of Nuclear Medicine.

Iodine-123 labeled nor-β-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography

J. Karhu, J. Tiihonen, M. Vauhkonen, 1997, European Journal of Nuclear Medicine.

Platelet function after single [153Sm]EDTMP therapy in prostate cancer.

B. Palumbo, H. Sinzinger, I. Palumbo, 2006, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Background, reasons and benefits using the vienna protocol for the treatment of painful bone recurrences with 153Samarium-EDTMP.

H. Sinzinger, J. Hiltunen, K. Weiss, 2009, Anticancer research.

Search for new and improved radiolabeling methods for monoclonal antibodies. A review of different methods.

J. Hiltunen, 1993, Acta oncologica.

Radiosynthesis of [123I]N-(3-iodoprop-(2E)-enyl)-2α-(imino-methyl)-3β-(3', 4'-dichlorophenyl) nortropane as a potential SPET tracer for dopamine transporter

A. Gee, A. Airaksinen, J. Kuikka, 2002 .

Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer’s disease

G. Sedvall, C. Halldin, L. Farde, 2000, Psychopharmacology.

Carbon-11 labelling of MADAM in two different positions: a highly selective PET radioligand for the serotonin transporter

Denis Guilloteau, Christer Halldin, Patrick Emond, 2001 .

Technetium-99m labelling of glycosylated somatostatin-14.

S. Nilsson, J. Hiltunen, M. Márquez, 2001, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Comparison of iodine-123 labelled 2β-carbomethoxy-3β-(4-iodophenyl)tropane and 2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain

J. Neumeyer, J. Kuikka, K. Bergström, 1995, European Journal of Nuclear Medicine.

Comparison of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain.

E. Länsimies, J. Neumeyer, J. Kuikka, 1995, European journal of nuclear medicine.

In vivo detection of vascular adhesion protein-1 in experimental inflammation.

R. Huupponen, J. Knuuti, S. Jalkanen, 2000, The American journal of pathology.

SPET imaging of central muscarinic acetylcholine receptors with iodine-123 labelled E-IQNP and Z-IQNP

G. Sedvall, C. Halldin, L. Farde, 2001, European Journal of Nuclear Medicine.